Emergent BioSolutions
Emergent BioSolutions

Emergent BioSolutions

Emergent BioSolutions High Paying Jobs, Compensation Information and Expert Network Connections

lightbulbWhat are the highest paying jobs at Emergent BioSolutions?

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. The company's gross revenue in 2018 was $782.4 million; gross income was $438.2 million; earnings before interest, taxes, depreciation, and amortization were $170.5 million.

Among the company's notable products are BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.

Fuad El-Hibri, the founder of the company and former CEO, led the company since its founding as BioPort Inc. until his retirement on April 1, 2012. El-Hibri continues to serve as the executive chairman of Emergent BioSolutions’ board of directors.

Highest paying job titles at Emergent BioSolutions include Quality Assurance Engineer, Quality Assurance Manager, and Senior Scientist


Market Cap$3.4 billion
Revenue$1.5 billion
5 Year Trendarrow trend up+26%
Net Income$305.1 million
pie chartAnnual Report
stats icon
Total value of jobs:
stats icon
Total Jobs:
stats icon
Average Pay:
stats icon
Total Experts:
stats icon
% Masters:

Top Experts at Emergent BioSolutions

hand in laptop pointing to email icon

Opportunities happen
…if you’re aware they’re there

Emergent BioSolutions Compensation

Quality Assurance Engineer



Average Compensation:$NaN

Quality Assurance Manager



Average Compensation:$120,000

Senior Scientist



Average Compensation:$225,000

Director, Clinical Development



Average Compensation:$NaN

View All Compensation blue arrow